Literature DB >> 4569769

An active antibody fragment (Fv) composed of the variable portions of heavy and light chains.

J Hochman, D Inbar, D Givol.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4569769     DOI: 10.1021/bi00730a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  24 in total

1.  Evolving concepts of specificity in immune reactions.

Authors:  Herman N Eisen; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 2.  Biosynthetic antibody binding sites: development of a single-chain Fv model based on antidinitrophenol IgA myeloma MOPC 315.

Authors:  J E McCartney; L Lederman; E A Drier; N A Cabral-Denison; G M Wu; R S Batorsky; J S Huston; H Oppermann
Journal:  J Protein Chem       Date:  1991-12

3.  The gross architecture of an antibody-combining site as determined by spin-label mapping.

Authors:  B J Sutton; P Gettins; D Givol; D Marsh; S Wain-Hobson; K J Willan; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

4.  Interactions of the lanthanide- and hapten-binding sites in the Fv fragment from the myeloma protein MOPC 315.

Authors:  R A Dwek; D Givol; R Jones; A C McLaughlin; S Wain-Hobson; A I White; C Wright
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

5.  Cold pepsin digestion: a novel method to produce the Fv fragment from human immunoglobulin M.

Authors:  L C Lin; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Recovery of immunoglobulin removed from lymphocytic surfaces by proteolysis.

Authors:  R P Eady; D W Hough; P J Kilshaw; G T Stevenson
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

7.  A functional examination of hapten-binding derivatives from a murine myeloma protein with immunoglobulin features.

Authors:  D C Merz; G W Litman; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

Review 8.  Immunotherapy in the poisoned patient. Overview of present applications and future trends.

Authors:  J B Sullivan
Journal:  Med Toxicol       Date:  1986 Jan-Feb

9.  Inhibition of immunoglobulin folding and secretion by dominant negative BiP ATPase mutants.

Authors:  L Hendershot; J Wei; J Gaut; J Melnick; S Aviel; Y Argon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

10.  Amino acid sequence of the Fv region of a human monoclonal IgM (protein WEA) with antibody activity against 3,4-pyruvylated galactose in Klebsiella polysaccharides K30 and K33.

Authors:  F Goñi; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.